"Venda sob prescrio de profissional habilitado, podendo este ser o nosso farmacutico de acordo com a Resoluo 586/2013 do Conselho de Farmcia
Read the guide Prior authorization New CMS rules, timeline protections, and what Washington beneficiaries can do when a plan delays or denies a drug or procedure authorization
Visceral fat correlates more strongly with cardiovascular disease risk, type 2 diabetes development, and mortality than subcutaneous fat
Unfortunately, no forms of government healthcare coverage are eligible for the LifeMD Weight Management Program, as these plans dont typically cover the type of medication LifeMD programs may prescribe
This is why the FDA approved phentermine only for short-term use, typically 12 weeks or less
Important context for emerging research: GLP-1 research may eventually inform future understanding of overlapping reward pathways Current evidence does not support GLP-1s as a treatment for co-occurring conditions GLP-1 medications are not part of existing evidence-based treatment pathways At this time, specialized, integrated care remains the standard for treating co-occurring eating disorders and substance use disorders
